Aromatase Inhibitory Activities of Standishinal and the Diterpenoids from the Bark of Thuja standishii

Abstract

The absolute stereostructure of a novel skeletal diterpene, standishinal (1), from the bark of Thuja standishii was confirmed by X-ray crystallographic analyses of 1 and its p-bromobenzoate derivative. Aromatase inhibitory activities of standishinal, eight known diterpenes, totarol, 12-methoxyabieta-8,11,13-trien-11-ol, 12-hydroxy-6,7-seco-abieta-8,11,13-triene-6,7-dial, trans-communic acid, labda-8(17),13-dien-12R,15-olid-19-oic acid, 12S-hydroxylabda-8(17),13(16),14-trien-19-oic acid, 13-oxo-15,16-dinorlabda-8(17),11E-dien-19-oic acid and 14-oxo-15-norlabda-8 (17),12E-dien-19-oic acid from the plant, and four synthetic analogs were evaluated using a recombinant human aromatase. Among them, standishinal and its diacetate derivative had significant inhibitory activities.

References

• 1 Ohtsu H, Iwamoto M, Ohishi H, Matsunaga S, Tanaka R. Standishinal, a novel carbon skeletal diterpene from the bark of Thuja standishii (Gord.) Carr.  Tetrahedron Letters. 1999;  40 6419-22
• 2 Iwamoto M, Ohtsu H, Ohishi H, Matsunaga S, Tanaka R. Labdane-type diterpenes and a nordrimane-type sesquiterpene from the stem bark of Thuja standishii .  Journal of Natural Products. 2000;  63 1381-3
• 3 Iwamoto M, Ohtsu H, Tokuda H, Nishino H, Matsunaga S, Tanaka R. Anti-tumor promoting diterpenes from the stem bark of Thuja standishii (Cupressaceae).  Bioorganic & Medicinal Chemistry. 2001;  9 1911-21
• 4 Tanaka R, Ohtsu H, Iwamoto M, Minami T, Tokuda H, Nishino H, Matsunaga S, Yoshitake A. Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr.  Cancer Letters. 2000;  161 165-70
• 5 Njar V C, Brodie A M. Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.  Drugs. 1999;  58 233-55
• 6 Kaufmann M, Bajetta E, Dirix L Y. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer.  Journal of Clinical Oncology. 2000;  18 1399-411
• 7 Blanco J G, Gil R R, Bocco J L, Genti-Raimondi S, Flury A. Aromatase inhibition by an 11,13-dihydroderivative of sesquiterpene lactone.  Journal of Pharmacology and Experimental Therapeutics. 2001;  297 1099-105
• 8 Gansser D, Spiteller G. Aromatase inhibitors from Urtica dioica roots.  Planta Medica. 1995;  61 138-40
• 9 Kellis J T Jr, Vickery L ET. Inhibition of human estrogen synthetase (aromatase) by flavones.  Science. 1984;  225 1032-4
• 10 Sheldrick G M. SHELXS-97, XP Molecular graphics V5. 10, 1997 Brucker AXS
• 11 Sheldrick G M. SHELXS-97, XP Molecular graphics V5. 10, 1990 Brucker AXS
• 12 Harada N. Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis.  Biochemical and Biophysical Research Communications. 1988;  156 725-35
• 13 Hayashi K, Sakaki E, Yabusaki Y, Komai K, Kaneko H, Nakatsuka I. Method for safety evaluation of chemical compounds using recombinant yeast expressing human cytochrome P-450. European patent 1995 EP064467
• 14 Pompon D, Liu R Y-K, Besman M J, Wang P-L, Shively J E, Chen S. Expression of human placental aromatase in Saccharomyces cerevisiae .  Molecular Endocrinology. 1989;  3 1477-87
• 15 Oeda K, Sakaki T, Ohkawa H. Expression of rat liver cytochrome P-450 MC cDNA in Saccharomyces cerevisiae .  DNA. 1985;  4 203-10
• 16 Lephart E D, Simpson E R. Assay of aromatase activity. Methods in Enzymology. Academic Press San Diego; 1991 206: 477-83